Characterization and quantitation of busulfan DNA adducts in the blood of patients receiving busulfan therapy

DNA alkylating drugs have been used as cancer chemotherapy with variable outcomes. The establishment of predictive biomarkers to identify patients who will effectively respond to treatment would allow for the development of personalized therapies. As the degree of interaction of alkylating drug with...

Descripción completa

Detalles Bibliográficos
Autores principales: Guidolin, Valeria, Li, Yupeng, Jacobs, Foster C., MacMillan, Margaret L., Villalta, Peter W., Hecht, Stephen S., Balbo, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938526/
https://www.ncbi.nlm.nih.gov/pubmed/36820303
http://dx.doi.org/10.1016/j.omto.2023.01.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938526/
https://www.ncbi.nlm.nih.gov/pubmed/36820303
http://dx.doi.org/10.1016/j.omto.2023.01.005

Ejemplares similares